General Information of the Compound
| Compound ID |
CP0429854
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-[3-(2,6-Diisopropyl-phenyl)-ureido]-N-((R)-2,2-dimethyl-4-phenyl-[1,3]dioxan-5-yl)-3-(1H-indol-3-yl)-2-methyl-propionamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C37H46N4O4
|
||||||||||||||||||
| Molecular Weight |
610.799
|
||||||||||||||||||
| Canonical SMILES |
CC(C)c1cccc(C(C)C)c1NC(=O)NC(C)(Cc1c[nH]c2ccccc12)C(=O)N[C@@H]1COC(C)(C)OC1c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C37H46N4O4/c1-23(2)27-17-13-18-28(24(3)4)32(27)40-35(43)41-37(7,20-26-21-38-30-19-12-11-16-29(26)30)34(42)39-31-22-44-36(5,6)45-33(31)25-14-9-8-10-15-25/h8-19,21,23-24,31,33,38H,20,22H2,1-7H3,(H,39,42)(H2,40,41,43)/t31-,33?,37?/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
PJFOFCXGUIDZLW-MGXPEAIDSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02814, Gastrin-releasing peptide receptor
Protein ID: PT02963, Neuromedin-B receptor